Jinhyun Cho

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

Jinhyun Cho, Hae Su Kim, Bo Mi Ku et al. · Journal of Clinical Oncology · 2018 · 343 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku et al. · Clinical Cancer Research · 2019 · 212 citations · Full text

Medicine, Oncology, Pharmacology +17

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer

Haa‐Na Song, Ki Sun Jung, Kwai Han Yoo et al. · Journal of Thoracic Oncology · 2015 · 109 citations · Full text

Medicine, Oncology, Pharmacology +10

Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment

Kyung Hwan Kim, Joon Young Hur, Jinhyun Cho et al. · OncoImmunology · 2020 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion

So Ree Kim, Eun Kyoung Kim, Jinhyun Cho et al. · Journal of the American College of Cardiology · 2020 · 50 citations

Medicine, Cardiology, Pharmacology +12